Figure 5 presents the cytoplasmic SAV1 immunoreactivity in the tumors of individual CRC patients in relation to the SAV1 immunoreactivity level in matched non-cancerous colorectal mucosa depending on N status (Figure 5A) and TNM stage (Figure 5B). This evidence concerns the gene SAV1 and colorectal carcinoma.